Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Solventum Corporation (SOLV) Profit Margins

Over the twelve months to 2026-06-30, Solventum Corporation (SOLV) had gross margin 54.7%, operating margin 25.0%, net margin 17.3%, free cash flow margin -1.4%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SOLVSolventum CorporationFollow SOLV — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
14.5B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin57.3%55.6%53.5%54.7%
Operating margin20.6%12.6%26.2%25.0%
Net margin16.4%5.8%18.7%17.3%
FCF margin19.8%9.8%-0.1%-1.4%

USD billions · SEC XBRL

Solventum Corporation — questions

What is Solventum Corporation's gross margin?
54.7% over the twelve months to 2026-06-30.
What is Solventum Corporation's operating margin?
25.0% over the twelve months to 2026-06-30.
What is Solventum Corporation's net profit margin?
17.3% over the twelve months to 2026-06-30.

Every figure on this page comes from Solventum Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.